Taro-Rivaroxaban 2.5 mg (Rivaroxaban TABLET) 2.5 MG

TARO-RIVAROXABAN 2.5 MG tablets are an oral medication used for blood clotting prevention. This anticoagulant helps manage conditions like deep vein thrombosis and pulmonary embolism. Learn more about rivaroxaban uses and benefits.

Strength

2.5 MG

Manufacturer / TM Owner

TARO PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TARO-RIVAROXABAN 2.5 MG tablets are primarily used to prevent blood clots in conditions like deep vein thrombosis and pulmonary embolism. Rivaroxaban is also used to reduce the risk of stroke in patients with atrial fibrillation. This medication works by inhibiting certain clotting factors in the blood, helping to maintain proper blood flow.

Side Effects

Common effects of TARO-RIVAROXABAN 2.5 MG tablets may include bleeding, bruising, and gastrointestinal discomfort. Some users may experience dizziness or fatigue. It's important to monitor for signs of unusual bleeding while taking this medication.

Precautions & Warnings

Handle TARO-RIVAROXABAN 2.5 MG tablets with care, as they can increase the risk of bleeding. Avoid activities that may cause injury or excessive bruising. Inform your healthcare provider about any other medications you are taking to prevent potential interactions.

Avoid Interactions

TARO-RIVAROXABAN 2.5 MG tablets may interact with other blood thinners, NSAIDs, and certain antibiotics. Alcohol consumption should be limited, as it can enhance the risk of bleeding. Always consult a healthcare professional before combining medications.

Frequently Asked Questions

TARO-RIVAROXABAN 2.5 MG tablets are used to prevent blood clots in conditions like deep vein thrombosis and pulmonary embolism, and to reduce stroke risk in atrial fibrillation.

Store TARO-RIVAROXABAN 2.5 MG tablets at room temperature, away from moisture and heat.

Common side effects may include bleeding, bruising, gastrointestinal discomfort, dizziness, and fatigue.

Consult a healthcare professional before combining TARO-RIVAROXABAN 2.5 MG with other medications to avoid potential interactions.

Long-term use of TARO-RIVAROXABAN 2.5 MG should be monitored by a healthcare professional to manage potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.